Skip to main content

Latest stock market podcasts

Part 2 Meet the Analyst: Dr. Tara Speranza, Bell Potter Analyst

Grady Wulff
February 23, 2023

Continue on to learn about the remaining stocks, Microba Life Sciences (ASX:MAP) and Monash IVF (ASX:MVF), as well as what to expect from these companies in 2023.

In this video, Dr. Tara discusses:
– (0:34) Impacts of Ferring’s FDA approval on Microba
– (5:30) Drivers behind Microba’s increase in revenue
– (7:12) What 2023 looks like for Monash IVF
– (8:39) Monash IVF’s rating
– (11:45) Monash IVF’s impact from legal action

Note: This interview was filmed on 7 February 2023.

From the helm: Brickworks' Lindsay Partridge

Bell Direct
February 12, 2020

Morning Bell 11 February

Bell Direct
February 10, 2020

Morning Bell 10 February

Bell Direct
February 9, 2020

Weekly Wrap 7 February

Bell Direct
February 7, 2020

Morning Bell 7 February

Bell Direct
February 6, 2020

Morning Bell 6 February

Bell Direct
February 5, 2020

Morning Bell 5 February

Bell Direct
February 4, 2020

Reporting season: Temple & Webster results

Bell Direct
February 4, 2020

Morning Bell 4 February

Bell Direct
February 3, 2020

Morning Bell 3 February

Bell Direct
February 2, 2020

January Market Overview

Bell Direct
January 31, 2020